U.S. Markets close in 1 hr 34 mins

Intellia Therapeutics, Inc. (NTLA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
37.77-1.50 (-3.82%)
As of 2:25PM EST. Market open.
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.58
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 340.29
52 Week Low 39.18
50-Day Moving Average 328.74
200-Day Moving Average 322.76

Share Statistics

Avg Vol (3 month) 3983.8k
Avg Vol (10 day) 3908.66k
Shares Outstanding 559.08M
Float 53.86M
% Held by Insiders 116.63%
% Held by Institutions 187.47%
Shares Short (Nov 12, 2020) 412.59M
Short Ratio (Nov 12, 2020) 413.08
Short % of Float (Nov 12, 2020) 429.75%
Short % of Shares Outstanding (Nov 12, 2020) 421.31%
Shares Short (prior month Oct 14, 2020) 412.79M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020

Profitability

Profit Margin -193.01%
Operating Margin (ttm)-198.85%

Management Effectiveness

Return on Assets (ttm)-19.24%
Return on Equity (ttm)-39.76%

Income Statement

Revenue (ttm)62.34M
Revenue Per Share (ttm)1.18
Quarterly Revenue Growth (yoy)109.30%
Gross Profit (ttm)-65.31M
EBITDA -117.68M
Net Income Avi to Common (ttm)-120.31M
Diluted EPS (ttm)-2.27
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)407.95M
Total Cash Per Share (mrq)6.91
Total Debt (mrq)22.2M
Total Debt/Equity (mrq)6.73
Current Ratio (mrq)7.45
Book Value Per Share (mrq)5.61

Cash Flow Statement

Operating Cash Flow (ttm)-38.35M
Levered Free Cash Flow (ttm)-39.65M